Company research
CARDINAL HEALTH INC
CIK 721371Updated Sep 24, 2026
SecurityCAH · NYSE · equity
Name history
CARDINAL HEALTH INC · through Sep 21, 2026CARDINAL DISTRIBUTION INC · through Feb 17, 1994
CAH price & chart
Loading TradingView…
NYSE:CAH on TradingView ↗In the news
Cardinal Health Board of Directors Approves Quarterly Dividend ↗
Seeking Alpha
Cardinal Health, Inc. (CAH) Presents at 2026 Global Healthcare Conference Transcript ↗
Cardinal Health, Inc. (CAH) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ↗
Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript ↗
Recent filings
Show 5 more recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 57,299,000,000Source | 53,122,000,000Source | 45,121,000,000Source | 43,417,000,000Source |
| Property, Plant and Equipment, NetUSD | 3,031,000,000Source | 2,858,000,000Source | 2,529,000,000Source | 2,462,000,000Source |
| GoodwillUSD | 11,442,000,000Source | 9,691,000,000Source | 4,725,000,000Source | 4,609,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,189,000,000Source | 2,486,000,000Source | 1,725,000,000Source | 1,472,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,856,000,000Source | 3,874,000,000Source | 5,133,000,000Source | 4,043,000,000Source |
| Inventory, NetUSD | 17,297,000,000Source | 16,831,000,000Source | 14,957,000,000Source | 15,940,000,000Source |
| Assets, CurrentUSD | 38,753,000,000Source | 36,373,000,000Source | 34,884,000,000Source | 33,833,000,000Source |
| Operating Lease, Right-of-Use AssetUSD | 991,000,000Source | 758,000,000Source | 475,000,000Source | 435,000,000Source |
| Other Assets, NoncurrentUSD | 1,884,000,000Source | 1,714,000,000Source | 1,258,000,000Source | 1,041,000,000Source |
| LIABILITIES AND EQUITY | ||||
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,887,000,000Source | 2,956,000,000Source | 2,917,000,000Source | 2,747,000,000Source |
| Retained Earnings (Accumulated Deficit)USD | 2,009,000,000Source | 783,000,000Source | -286,000,000Source | -534,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -165,000,000Source | -155,000,000Source | -167,000,000Source | -151,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | -2,883,000,000Source | -2,781,000,000Source | -3,213,000,000Source | -2,852,000,000Source |
| Liabilities and EquityUSD | 57,299,000,000Source | 53,122,000,000Source | 45,121,000,000Source | 43,417,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 43,904,000,000Source | 38,897,000,000Source | 35,640,000,000Source | 33,706,000,000Source |
| Operating Lease, Liability, CurrentUSD | 201,000,000Source | 164,000,000Source | 117,000,000Source | 100,000,000Source |
| Accounts Payable, CurrentUSD | 38,283,000,000Source | 34,713,000,000Source | 31,759,000,000Source | 29,813,000,000Source |
| Operating Lease, Liability, NoncurrentUSD | 861,000,000Source | 654,000,000Source | 400,000,000Source | 375,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 159,000,000Source | 147,000,000Source | 1,000,000Source | 1,000,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 2,307,000,000Source | 2,300,000,000Source | 1,972,000,000Source | 2,045,000,000Source |
| Short-term InvestmentsUSD | — | — | 200,000,000Source | — |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 1,705,000,000Source | 1,569,000,000Source | 853,000,000Source | 262,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 956,000,000Source | 790,000,000Source | 710,000,000Source | 692,000,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 367,000,000Source | 244,000,000Source | 121,000,000Source | 96,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 488,000,000Source | 1,816,000,000Source | -1,115,000,000Source | 340,000,000Source |
| Increase (Decrease) in Accounts PayableUSD | 3,463,000,000Source | 2,732,000,000Source | 1,824,000,000Source | 2,718,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | 91,000,000Source | 243,000,000Source | -104,000,000Source | -31,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 5,174,000,000Source | 2,397,000,000Source | 3,762,000,000Source | 2,839,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 1,991,000,000Source | 5,250,000,000Source | 1,190,000,000Source | 10,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -2,584,000,000Source | -5,593,000,000Source | -1,849,000,000Source | -454,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 649,000,000Source | 547,000,000Source | 511,000,000Source | 481,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 1,358,000,000Source | 765,000,000Source | 750,000,000Source | 2,000,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -1,602,000,000Source | 1,940,000,000Source | -847,000,000Source | -3,051,000,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 491,000,000Source | 494,000,000Source | 499,000,000Source | 525,000,000Source |
| Repayments of Long-term DebtUSD | 653,000,000Source | 445,000,000Source | 783,000,000Source | 579,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 982,000,000Source | -1,259,000,000Source | 1,057,000,000Source | -674,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 4,856,000,000Source | 3,874,000,000Source | 5,133,000,000Source | 4,043,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 406,000,000Source | 315,000,000Source | 214,000,000Source | 203,000,000Source |
| Income Taxes Paid, NetUSD | 338,000,000Source | 444,000,000Source | 191,000,000Source | 156,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -6,000,000Source | -3,000,000Source | -9,000,000Source | -8,000,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 122,000,000Source | 121,000,000Source | 121,000,000Source | 96,000,000Source |
| Amortization of Intangible AssetsUSD | 361,000,000Source | 303,000,000Source | 264,000,000Source | 281,000,000Source |
| DepreciationUSD | 589,000,000Source | 488,000,000Source | 470,000,000Source | 441,000,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | 122,000,000Source | — | — | — |
| Gain (Loss) on Sale of InvestmentsUSD | — | — | 0Source | 0Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | -177,000,000Source | -18,000,000Source | -634,000,000Source | -1,250,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 10,000,000Source | 185,000,000Source | -78,000,000Source | 302,000,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source |
| GoodwillUSD | 11,442,000,000Source | 9,691,000,000Source | 4,725,000,000Source | 4,609,000,000Source |
| Goodwill, Impairment LossUSD | 184,000,000Source | — | 675,000,000Source | 1,231,000,000Source |
| Income Tax Expense (Benefit)USD | 469,000,000Source | 532,000,000Source | 348,000,000Source | 376,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,714,000,000Source | 1,561,000,000Source | 852,000,000Source | 261,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -9,000,000Source | 8,000,000Source | 1,000,000Source | 1,000,000Source |
| Other Nonoperating Income (Expense)USD | 31,000,000Source | 41,000,000Source | 9,000,000Source | 4,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 1,000,000,000Source | 2,900,000,000Source | 1,140,000,000Source | — |
| Restructuring CostsUSD | 46,000,000Source | 40,000,000Source | 87,000,000Source | 43,000,000Source |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 254,248,000,000Source | 222,578,000,000Source | 226,827,000,000Source | 205,012,000,000Source |
| Cost of RevenueUSD | 244,474,000,000Source | 214,410,000,000Source | 219,413,000,000Source | 198,123,000,000Source |
| Selling, General and Administrative ExpenseUSD | 6,132,000,000Source | 5,382,000,000Source | 5,000,000,000Source | 4,834,000,000Source |
| Operating Income (Loss)USD | 2,613,000,000Source | 2,275,000,000Source | 1,243,000,000Source | 727,000,000Source |
| Other Nonoperating Income (Expense)USD | 31,000,000Source | 41,000,000Source | 9,000,000Source | 4,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 2,174,000,000Source | 2,101,000,000Source | 1,201,000,000Source | 638,000,000Source |
| Income Tax Expense (Benefit)USD | 469,000,000Source | 532,000,000Source | 348,000,000Source | 376,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -9,000,000Source | 8,000,000Source | 1,000,000Source | 1,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 1,714,000,000Source | 1,561,000,000Source | 852,000,000Source | 261,000,000Source |
| Earnings Per Share, BasicUSD per share | 7.27Source | 6.48Source | 3.48Source | 1Source |
| Earnings Per Share, DilutedUSD per share | 7.23Source | 6.45Source | 3.45Source | 1Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 236,000,000Source | 241,000,000Source | 245,000,000Source | 261,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 237,000,000Source | 242,000,000Source | 247,000,000Source | 262,000,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 361,000,000Source | 303,000,000Source | 264,000,000Source | 281,000,000Source |
| Current Income Tax Expense (Benefit)USD | 378,000,000Source | 289,000,000Source | 452,000,000Source | 407,000,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | 10,000,000Source | 185,000,000Source | -78,000,000Source | 302,000,000Source |
| Goodwill, Impairment LossUSD | 184,000,000Source | — | 675,000,000Source | 1,231,000,000Source |
| Gross ProfitUSD | 9,774,000,000Source | 8,168,000,000Source | 7,414,000,000Source | 6,889,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 1,753,000,000Source | 1,715,000,000Source | 892,000,000Source | 291,000,000Source |
| Interest ExpenseUSD | 348,000,000Source | 215,000,000Source | 51,000,000Source | 93,000,000Source |
| Restructuring CostsUSD | 46,000,000Source | 40,000,000Source | 87,000,000Source | 43,000,000Source |
Filing attachments
d51052dex42.htm · 8-K · 2025-08-27
EX-4.2 2 d51052dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 CARDINAL HEALTH, INC., as Issuer and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee THIRD SUPPLEMENTAL INDENTURE Dated as of August 27, 2025 to INDENTURE Dated as of June 2, 2008 4.500% Notes due 2030 5.150% Notes due 2035 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND OTHER PROVISIONS…
Read attachment ↗